Evidence map›Paper›PMID 34749748›Full record

ArticleLipids in health and disease2021

The effects of genetic polymorphisms of APOE on circulating lipid levels in middle-aged and elderly chinese Fujian Han population: toward age- and sex-personalized management.

Xiaofeng Liu, Qingwen Lin, Kengna Fan, Minjie Tang, Weiqing Zhang, Bin Yang, Qishui Ou

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Correlation ofWorld journal of cardiology · 2025
    Article
  3. International journal of general medicine · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Association betweenInternational journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xiaofeng LiuDepartment of Laboratory Medicine, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, 350005, Fuzhou, China. liuchognyang555@126.com.
Qingwen LinDepartment of Laboratory Medicine, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, 350005, Fuzhou, China.
Kengna FanDepartment of Laboratory Medicine, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, 350005, Fuzhou, China.
Minjie TangDepartment of Laboratory Medicine, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, 350005, Fuzhou, China.
Weiqing ZhangDepartment of Laboratory Medicine, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, 350005, Fuzhou, China.
Bin YangDepartment of Laboratory Medicine, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, 350005, Fuzhou, China.
Qishui OuDepartment of Laboratory Medicine, the First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, 350005, Fuzhou, China. ouqishui@fjmu.edu.cn.
Fujian Medical University · CNFirst Affiliated Hospital of Fujian Medical University · CN

Funding

fujian provincial department of science and technology 2018Y9080national natural science foundation of china 81802088
6 · The paper itself

Abstract

backgroundIncreased evidence has reported the association of genetic polymorphisms of Apolipoprotein E (APOE) with serum lipids. However, few studies have explored the combined effects of APOE, gender, and age.

methodsA total of 1,419 middle-aged and elderly subjects were randomly selected and studied. The APOE genotypes and the serum lipids were detected. The effects of APOE, gender, and age on serum lipids were preliminarily observed in general. The subjects were then divided into the middle-aged group (40-64 years old) and the elderly group (≥ 65 years old), for both males and females, to explore the combined effects of the APOE, gender, and age on serum lipids. Finally, a multivariate logistic regression model was used to evaluate the associations between the APOE allele carriers and the at-risk levels of dyslipidemia.

resultsThe serum TC, LDL-C, and ApoB in the ε2 carriers were lower than the ε3 carriers (all P < 0.05), and there was no significant difference in the ε4 carriers compared to the ε3 carriers in general (all P > 0.05). The serum LDL-C and ApoB of the ε2 carriers were lower than the noncarriers in the middle-aged and elderly males (all P < 0.05). The serum TC in the ε2 carriers was lower than the noncarriers only in middle-aged males (P < 0.05). As to the levels of serum HDL-C and ApoA1, the ε2 carriers were higher than the noncarriers in middle-aged females (all P < 0.05), and the ε4 carriers were lower than noncarriers in middle-aged males (P < 0.05). Especially, the serum TG in the ε4 carriers was significantly higher than the noncarriers in elderly females. The logistic regression analysis indicated that the ε2 carriers were less likely to have at-risk levels of high LDL-C in middle-aged and elderly males (all P < 0.05) versus low HDL-C in middle-aged females (P < 0.05). In contrast, the ε4 carriers were more likely to have at-risk levels of high TG in elderly females (P < 0.05).

conclusionsThe effects of the genetic polymorphisms of APOE on the serum lipids were both gender- and age-dependent in the middle-aged and elderly Chinese Fujian Han population.

Indexed as

Polymorphism, GeneticAdultAgedAged, 80 and overAgingApolipoproteins EAsian PeopleDyslipidemiasFemaleGene FrequencyGenetic Predisposition to DiseaseHumansLipidsMaleMiddle AgedApoE protein, humanApolipoproteins ELipidsApolipoprotein EGenderGenetic polymorphismGeriatricsSerum lipids

Identifiers

PMID34749748
PMCPMC8573895
OpenAlexW3214476537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.